TraCS Member Lisa Carey Marks 200th Anniversary of NEJM

Lisa A. Carey, M.D., the Richardson and Marilyn Jacobs Preyer Distinguished Professorship in Breast Cancer Research, presented an invited lecture June 26, at Harvard Medical School to mark the 200th anniversary of the New England Journal of Medicine’s founding. Dr. Carey is part of a panel on breast cancer, moderated by Robert Mayer, M.D., of the Dana-Farber Cancer Institute and featuring Marc Lippman, M.D., from the University of Miami, Robin Roberts from ABC News and George Sledge, M.D., from Indiana University.

Dr. Carey is medical director of the UNC Breast Center and associate director for Clinical Research at UNC Lineberger Comprehensive Cancer Center and a member of the North Carolina Clinical and Translational Sciences Institute (NC TraCS), home of UNC’s NIH Clinical and Translational Science Awards (CTSA).

A member of UNC’s faculty since 1998, Dr. Carey is a leading figure in North Carolina’s breast cancer research efforts. She and her colleagues at UNC have written widely on racial disparities in breast cancer development and mortality, and she has led multiple clinical trials, in North Carolina and nationally, investigating new drugs and approaches in breast cancer. Dr. Carey also serves on several national cancer committees, such as the National Cancer Institute (NCI)’s Breast Cancer Steering Committee. She was awarded a Doris Duke Clinician Scientist Award in 1999, a Career Development Award from the National Cancer Institute in 2000, was inducted into Johns Hopkins Society of Scholars in 2008, and received the NCI Director’s Service Award in 2011. She was recently appointed to the board of Blue Cross Blue Shield of North Carolina.

Dr. Carey attended Wellesley College, and earned her M.D. from the Johns Hopkins School of Medicine. She completed her residency and fellowship in medical oncology at Johns Hopkins.